المؤلفون: Butler, Javed, Anker, Stefan D., Lund, Lars H, Coats, Andrew J. S., Filippatos, Gerasimos, Siddiqi, Tariq Jamal, Friede, Tim, Fabien, Vincent, Kosiborod, Mikhail, Metra, Marco, Piña, Ileana L., Pinto, Fausto J., Rossignol, Patrick, van der Meer, Peter, Bahit, Cecilia, Belohlavek, Jan, Böhm, Michael, Brugts, Jasper J., Cleland, John G. F., Ezekowitz, Justin, Bayes-Genis, Antoni, Gotsman, Israel, Goudev, Assen, Khintibidze, Irakli, Lindenfeld, Joann, Mentz, Robert J., Merkely, Bela, Montes, Eliodoro Castro, Mullens, Wilfried, Nicolau, Jose C., Parkhomenko, Aleksandr, Ponikowski, Piotr, Seferovic, Petar M., Senni, Michele, Shlyakhto, Evgeny, Cohen-Solal, Alain, Szecsödy, Peter, Jensen, Klaus, Dorigotti, Fabio, Weir, Matthew R., Pitt, Bertram

مصطلحات موضوعية: Heart failure with reduced ejection fraction, Hyperkalemia, Patiromer, Potassium-binding polymer, Renin–angiotensin–aldosterone system inhibitor (RAASi)

العلاقة: https://academic.oup.com/eurheartjTest; Eur Heart J. 2022 Nov 1;43(41):4362-4373; http://hdl.handle.net/10451/61692Test

الإتاحة: https://doi.org/10.1093/eurheartj/ehac401Test
http://hdl.handle.net/10451/61692Test

المؤلفون: Welsh, Aimee, Hammad, Muhammad, Piña, Ileana L, Kulinski, Jacquelyn

المصدر: European Journal of Preventive Cardiology ; ISSN 2047-4873 2047-4881

الإتاحة: https://doi.org/10.1093/eurjpc/zwae025Test

المؤلفون: Benjamin, Emelia J, Al‐Khatib, Sana M, Desvigne‐Nickens, Patrice, Alonso, Alvaro, Djoussé, Luc, Forman, Daniel E, Gillis, Anne M, Hendriks, Jeroen ML, Hills, Mellanie True, Kirchhof, Paulus, Link, Mark S, Marcus, Gregory M, Mehra, Reena, Murray, Katherine T, Parkash, Ratika, Piña, Ileana L, Redline, Susan, Rienstra, Michiel, Sanders, Prashanthan, Somers, Virend K, Van Wagoner, David R, Wang, Paul J, Cooper, Lawton S, Go, Alan S

المصدر: Journal of the American Heart Association. 10(16)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Clinical Research, Comparative Effectiveness Research, Cardiovascular, Prevention, Clinical Trials and Supportive Activities, Heart Disease, Stroke, Good Health and Well Being, Animals, Anti-Arrhythmia Agents, Atrial Fibrillation, Biomedical Research, Body Composition, Cardiac Rehabilitation, Comorbidity, Disease Progression, Health Priorities, Health Services Needs and Demand, Healthy Lifestyle, Humans, National Heart, Lung, and Blood Institute (U.S.), Needs Assessment, Recurrence, Research Design, Risk Assessment, Risk Factors, Secondary Prevention, Treatment Outcome, United States, Weight Loss, atrial fibrillation, cardiac rehabilitation, prevention, research, risk factors, sleep, Cardiorespiratory Medicine and Haematology, Cardiovascular medicine and haematology

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/9r84k5c2Test

المؤلفون: Reza, Nosheen, Tahhan, Ayman Samman, Mahmud, Nadim, DeFilippis, Ersilia M, Alrohaibani, Alaaeddin, Vaduganathan, Muthiah, Greene, Stephen J, Ho, Annie Hang, Fonarow, Gregg C, Butler, Javed, O’Connor, Christopher, Fiuzat, Mona, Vardeny, Orly, Piña, Ileana L, Lindenfeld, JoAnn, Jessup, Mariell

المصدر: Circulation Heart Failure. 13(8)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Medical Physiology, Cardiovascular Medicine and Haematology, Cardiovascular, Heart Disease, Clinical Research, Clinical Trials and Supportive Activities, Gender Equality, Authorship, Cardiology, Europe, Female, Humans, Manuscripts, Medical as Topic, Publishing, United States, Women, clinical trial, guideline, heart failure, publications, women, Biochemistry and Cell Biology, Cardiorespiratory Medicine and Haematology, Cardiovascular System & Hematology, Cardiovascular medicine and haematology, Medical physiology

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/8vr3z7q0Test

المؤلفون: Khan, Muhammad Shahzeb, Butler, Javed, Anker, Stefan, D, Filippatos, Gerasimos, Ferreira, João Pedro, Pocock, Stuart, J, Januzzi, James, L, Piña, Ileana, L, Böhm, Michael, Ponikowski, Piotr, Verma, Subodh, Brueckmann, Martina, Vedin, Ola, Zeller, Cordula, Zannad, Faiez, Packer, Milton

المساهمون: Duke University Durham, Baylor Scott and White Research Institute Dallas, TX, USA, Department of Medicine, University of Mississippi School of Medicine, Berlin-Brandenburg Center for Regenerative Medicine Berlin, Germany (BCRT), Charité - UniversitätsMedizin = Charité - University Hospital Berlin, German Center for Cardiovascular Research (DZHK), Berlin Institute of Health (BIH), Wrocław Medical University, National and Kapodistrian University of Athens (NKUA), “Attikon” University Hospital, Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT ), London School of Hygiene and Tropical Medicine (LSHTM), Massachusetts General Hospital Boston, Central Michigan University (CMU), Wayne State University Detroit, Saarland University Saarbrücken, University of Wrocław Poland (UWr), St. Michael's Hospital, Boehringer Ingelheim International GmbH, Universität Heidelberg Heidelberg = Heidelberg University, University Hospital Mannheim, Boehringer Ingelheim AB, Stockholm, Boehringer Ingelheim Pharma GmbH & Co. KG, Baylor Heart and Vascular Institute, Baylor University Medical Center, Imperial College London, The EMPEROR‐Reduced trial was funded by the Boehringer Ingelheim & Eli Lilly and Company.

المصدر: ISSN: 2047-9980 ; Journal of the American Heart Association ; https://hal.univ-lorraine.fr/hal-03918171Test ; Journal of the American Heart Association, 2023, 12 (1), pp.e027652. ⟨10.1161/JAHA.122.027652⟩.

مصطلحات موضوعية: [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36565199; hal-03918171; https://hal.univ-lorraine.fr/hal-03918171Test; https://hal.univ-lorraine.fr/hal-03918171/documentTest; https://hal.univ-lorraine.fr/hal-03918171/file/JAHA.122.027652.pdfTest; PUBMED: 36565199

الإتاحة: https://doi.org/10.1161/JAHA.122.027652Test
https://hal.univ-lorraine.fr/hal-03918171Test
https://hal.univ-lorraine.fr/hal-03918171/documentTest
https://hal.univ-lorraine.fr/hal-03918171/file/JAHA.122.027652.pdfTest

المؤلفون: Butler, Javed, Usman, Muhammad Shariq, Filippatos, Gerasimos, Ferreira, João Pedro, Böhm, Michael, Brueckmann, Martina, Januzzi, James, L, Kaul, Sanjay, Piña, Ileana, L, Ponikowski, Piotr, Senni, Michele, Sumin, Mikhail, Verma, Subodh, Zaremba-Pechmann, Liliana, Pocock, Stuart, J, Packer, Milton, Anker, Stefan

المساهمون: Baylor Scott and White Research Institute Dallas, TX, USA, University of Mississippi Medical Center (UMMC), “Attikon” University Hospital, National and Kapodistrian University of Athens (NKUA), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT ), Saarland University Hospital (UKS), Universität des Saarlandes Saarbrücken, Boehringer Ingelheim International GmbH, Medizinische Fakultät Mannheim, Universität Heidelberg Heidelberg = Heidelberg University, Massachusetts General Hospital Boston, MA, USA, Harvard Medical School Boston (HMS), Baim Institute for Clinical Research Boston MA, Cedars-Sinai Medical Center, Central Michigan University (CMU), Wrocław Medical University, Azienda Ospedaliera Ospedale Papa Giovanni XXIII Bergamo, Italy, St. Michael's Hospital, University of Toronto, Elderbrook Solutions GmbH on behalf of Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, London School of Hygiene and Tropical Medicine (LSHTM), Imperial College London, Baylor Heart and Vascular Institute, Baylor University Medical Center, Berlin-Brandenburg Center for Regenerative Medicine Berlin, Germany (BCRT), Charité - UniversitätsMedizin = Charité - University Hospital Berlin, German Center for Cardiovascular Research (DZHK), Berlin Institute of Health (BIH), The EMPEROR-Preserved trial was funded by the Boehringer Ingelheim and Eli Lilly and Company Diabetes Alliance

المصدر: ISSN: 2380-6583.

مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37223933; hal-04105856; https://hal.univ-lorraine.fr/hal-04105856Test; https://hal.univ-lorraine.fr/hal-04105856/documentTest; https://hal.univ-lorraine.fr/hal-04105856/file/jamacardiology_butler_2023_oi_230021_1684420487.3776.pdfTest; PUBMED: 37223933; PUBMEDCENTRAL: PMC10209829

الإتاحة: https://doi.org/10.1001/jamacardio.2023.1090Test
https://hal.univ-lorraine.fr/hal-04105856Test
https://hal.univ-lorraine.fr/hal-04105856/documentTest
https://hal.univ-lorraine.fr/hal-04105856/file/jamacardiology_butler_2023_oi_230021_1684420487.3776.pdfTest

المؤلفون: Khan, Muhammad Shahzeb, Anker, Stefan, D, Filippatos, Gerasimos, Ferreira, João Pedro, Pocock, Stuart, J, Januzzi, James, L, Chopra, Vijay, K, Piña, Ileana, L, Böhm, Michael, Ponikowski, Piotr, Verma, Subodh, Brueckmann, Martina, Vedin, Ola, Peil, Barbara, Zannad, Faiez, Packer, Milton, Butler, Javed

المساهمون: Duke University Durham, Berlin-Brandenburg Center for Regenerative Medicine Berlin, Germany (BCRT), Charité - UniversitätsMedizin = Charité - University Hospital Berlin, German Center for Cardiovascular Research (DZHK), Berlin Institute of Health (BIH), National and Kapodistrian University of Athens (NKUA), “Attikon” University Hospital, Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT ), Faculdade de Medicina da Universidade do Porto (FMUP), Universidade do Porto = University of Porto, Heart Failure Clinic, Centro Hospitalar de Vila Nova de Gaia/Espinho, Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), London School of Hygiene and Tropical Medicine (LSHTM), Massachusetts General Hospital Boston, Harvard Medical School Boston (HMS), Department of Cardiology, Medanta, Gurgaon, Haryana, Jefferson (Philadelphia University + Thomas Jefferson University), Saarland University Saarbrücken, Wrocław Medical University, St. Michael's Hospital, University of Toronto, Boehringer Ingelheim International GmbH, Universität Heidelberg Heidelberg = Heidelberg University, Boehringer Ingelheim AB, Stockholm, Baylor College of Medecine, Imperial College London, Baylor Scott & White Research Institute (BSWRI), University of Southern Mississippi (USM), The EMPEROR-Reduced trial was funded by the Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance.

المصدر: ISSN: 1071-9164 ; Journal of Cardiac Failure ; https://hal.univ-lorraine.fr/hal-04192638Test ; Journal of Cardiac Failure, 2023, 29 (10), pp.1345-1354. ⟨10.1016/j.cardfail.2023.06.024⟩.

مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37558088; hal-04192638; https://hal.univ-lorraine.fr/hal-04192638Test; https://hal.univ-lorraine.fr/hal-04192638/documentTest; https://hal.univ-lorraine.fr/hal-04192638/file/1-s2.0-S1071916423002750-main.pdfTest; PUBMED: 37558088

الإتاحة: https://doi.org/10.1016/j.cardfail.2023.06.024Test
https://hal.univ-lorraine.fr/hal-04192638Test
https://hal.univ-lorraine.fr/hal-04192638/documentTest
https://hal.univ-lorraine.fr/hal-04192638/file/1-s2.0-S1071916423002750-main.pdfTest

المؤلفون: Siddiqi, Tariq Jamal, Anker, Stefan, D, Filippatos, Gerasimos, Ferreira, João Pedro, Pocock, Stuart, J, Böhm, Michael, Brueckmann, Martina, Chopra, Vijay, K, Iwata, Tomoko, Januzzi, James, L, Piña, Ileana, L., Ponikowski, Piotr, Senni, Michele, Vedin, Ola, Verma, Subodh, Zhang, Yuhui, Zannad, Faiez, Packer, Milton, Butler, Javed

المساهمون: University of Mississippi Medical Center (UMMC), Berlin-Brandenburg Center for Regenerative Therapies Berlin, Germany, Charité - UniversitätsMedizin = Charité - University Hospital Berlin, German Center for Cardiovascular Research (DZHK), Berlin Institute of Health (BIH), National and Kapodistrian University of Athens (NKUA), “Attikon” University Hospital, Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT ), Heart Failure Clinic, Centro Hospitalar de Vila Nova de Gaia/Espinho, Cardiovascular R&D Centre-UnIC@RISE, Faculdade de Medicina da Universidade do Porto (FMUP), Universidade do Porto = University of Porto, London School of Hygiene and Tropical Medicine (LSHTM), Saarland University Saarbrücken, Saarland University Hospital (UKS), Boehringer Ingelheim International GmbH, University of Heidelberg, Medical Faculty, Max Super Speciality Hospital, Boehringer Ingelheim Pharma GmbH & Co. KG, Massachusetts General Hospital Boston, Baim Institute for Clinical Research Boston MA, Central Michigan University (CMU), Wrocław Medical University, Azienda Ospedaliera Ospedale Papa Giovanni XXIII Bergamo, Italy, Boehringer Ingelheim AB, Stockholm, University of Toronto, St. Michael's Hospital, Peking Union Medical College Hospital Beijing (PUMCH), China Academy of Chinese Medical Sciences, Imperial College London, Baylor Scott & White Research Institute (BSWRI), The EMPEROR-Preserved trial (NCT03057951) was funded by the Boehringer Ingelheim and Eli Lilly and Company Diabetes Alliance.

المصدر: ISSN: 1388-9842 ; European Journal of Heart Failure ; https://hal.univ-lorraine.fr/hal-04106809Test ; European Journal of Heart Failure, 2023, ⟨10.1002/ejhf.2831⟩.

مصطلحات موضوعية: Empagliflozin, Heart failure with preserved ejection fraction, Kansas City Cardiomyopathy, Questionnaire, [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36974746; hal-04106809; https://hal.univ-lorraine.fr/hal-04106809Test; https://hal.univ-lorraine.fr/hal-04106809/documentTest; https://hal.univ-lorraine.fr/hal-04106809/file/European%20J%20of%20Heart%20Fail%20-%202023%20-%20Siddiqi%20-%20Health%20status%20across%20major%20subgroups%20of%20patients%20with%20heart%20failure%20and.pdfTest; PUBMED: 36974746

الإتاحة: https://doi.org/10.1002/ejhf.2831Test
https://hal.univ-lorraine.fr/hal-04106809Test
https://hal.univ-lorraine.fr/hal-04106809/documentTest
https://hal.univ-lorraine.fr/hal-04106809/file/European%20J%20of%20Heart%20Fail%20-%202023%20-%20Siddiqi%20-%20Health%20status%20across%20major%20subgroups%20of%20patients%20with%20heart%20failure%20and.pdfTest

المؤلفون: Ezekowitz, Justin A., McMullan, Ciaran J., Westerhout, Cynthia M., Piña, Ileana L., Lopez-Sendon, Jose, Anstrom, Kevin J., Hernandez, Adrian F., Lam, Carolyn S.P., O'Connor, Christopher M., Pieske, Burkert, Ponikowski, Piotr, Roessig, Lothar, Voors, Adriaan A., Koglin, Joerg, Armstrong, Paul W., Butler, Javed

المصدر: Ezekowitz , J A , McMullan , C J , Westerhout , C M , Piña , I L , Lopez-Sendon , J , Anstrom , K J , Hernandez , A F , Lam , C S P , O'Connor , C M , Pieske , B , Ponikowski , P , Roessig , L , Voors , A A , Koglin , J , Armstrong , P W & Butler , J 2023 , ' Background Medical Therapy and Clinical Outcomes from the VICTORIA Trial ' , Circulation: Heart Failure , vol. 16 , no. 9 , ....

مصطلحات موضوعية: heart failure with reduced ejection fraction, hospitalization, mortality, standard of care, vericiguat

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/370bea3f-a4b0-4006-83d8-9f8b695f1860Test

الإتاحة: https://doi.org/10.1161/CIRCHEARTFAILURE.123.010599Test
https://hdl.handle.net/11370/370bea3f-a4b0-4006-83d8-9f8b695f1860Test
https://research.rug.nl/en/publications/370bea3f-a4b0-4006-83d8-9f8b695f1860Test
https://pure.rug.nl/ws/files/912717492/Background_Medical_Therapy_and_Clinical_Outcomes_From_the_VICTORIA_Trial.pdfTest
http://www.scopus.com/inward/record.url?scp=85170526165&partnerID=8YFLogxKTest

المؤلفون: Khan, Muhammad Shahzeb, Anker, Stefan D., Friede, Tim, Jankowska, Ewa A., Metra, Marco, Piña, Ileana L., Coats, Andrew J.S., Rosano, Giuseppe, Roubert, Bernard, Goehring, Udo-Michael, Dorigotti, Fabio, Comin-Colet, Josep, van Veldhuisen, Dirk J., Filippatos, Gerasimos S., Ponikowski, Piotr, Butler, Javed

المصدر: Khan , M S , Anker , S D , Friede , T , Jankowska , E A , Metra , M , Piña , I L , Coats , A J S , Rosano , G , Roubert , B , Goehring , U-M , Dorigotti , F , Comin-Colet , J , van Veldhuisen , D J , Filippatos , G S , Ponikowski , P & Butler , J 2023 , ' Minimal Clinically Important Differences in 6-Minute Walk Test in Patients With HFrEF and Iron Deficiency : MCID for 6MWT in patients with HFrEF and ....

مصطلحات موضوعية: 6-minute walk test, Heart failure with reduced ejection fraction, minimal clinically important difference

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/1c15072b-185b-4b0d-9e14-8a9da1e9f73bTest

الإتاحة: https://doi.org/10.1016/j.cardfail.2022.10.423Test
https://hdl.handle.net/11370/1c15072b-185b-4b0d-9e14-8a9da1e9f73bTest
https://research.rug.nl/en/publications/1c15072b-185b-4b0d-9e14-8a9da1e9f73bTest
https://pure.rug.nl/ws/files/691487874/Minimal_Clinically_Important_Differences_in_6_Minute_Walk_Test_in_Patients_With_HFrEF_and_Iron_Deficiency.pdfTest